Research Portal

Role of the C-terminal actin binding domain in BCR/ABL-mediated survival and drug resistance.

Research output: Contribution to journal › Article › peer-review

Standard Standard

Role of the C-terminal actin binding domain in BCR/ABL-mediated survival and drug resistance. / N, Underhill-Day; Pierce, Andrew; SE, Thompson et al.
In: British Journal of Haematology, Vol. 132, No. 6, 13.02.2006, p. 774-783.

Research output: Contribution to journal › Article › peer-review

HarvardHarvard

N, U-D, Pierce, A, SE, T, D, X, AD, W & PJ, O-L 2006, 'Role of the C-terminal actin binding domain in BCR/ABL-mediated survival and drug resistance.', British Journal of Haematology, vol. 132, no. 6, pp. 774-783. https://doi.org/10.1111/j.1365-2141.2005.05949.x

APA

N, U.-D., Pierce, A., SE, T., D, X., AD, W., & PJ, O.-L. (2006). Role of the C-terminal actin binding domain in BCR/ABL-mediated survival and drug resistance. British Journal of Haematology, 132(6), 774-783. https://doi.org/10.1111/j.1365-2141.2005.05949.x

CBE

N U-D, Pierce A, SE T, D X, AD W, PJ O-L. 2006. Role of the C-terminal actin binding domain in BCR/ABL-mediated survival and drug resistance. British Journal of Haematology. 132(6):774-783. https://doi.org/10.1111/j.1365-2141.2005.05949.x

MLA

N, Underhill-Day et al. "Role of the C-terminal actin binding domain in BCR/ABL-mediated survival and drug resistance.". British Journal of Haematology. 2006, 132(6). 774-783. https://doi.org/10.1111/j.1365-2141.2005.05949.x

VancouverVancouver

N UD, Pierce A, SE T, D X, AD W, PJ OL. Role of the C-terminal actin binding domain in BCR/ABL-mediated survival and drug resistance. British Journal of Haematology. 2006 Feb 13;132(6):774-783. doi: 10.1111/j.1365-2141.2005.05949.x

Author

N, Underhill-Day ; Pierce, Andrew ; SE, Thompson et al. / Role of the C-terminal actin binding domain in BCR/ABL-mediated survival and drug resistance. In: British Journal of Haematology. 2006 ; Vol. 132, No. 6. pp. 774-783.

RIS

TY - JOUR

T1 - Role of the C-terminal actin binding domain in BCR/ABL-mediated survival and drug resistance.

AU - N, Underhill-Day

AU - Pierce, Andrew

AU - SE, Thompson

AU - D, Xenaki

AU - AD, Whetton

AU - PJ, Owen-Lynch

PY - 2006/2/13

Y1 - 2006/2/13

U2 - 10.1111/j.1365-2141.2005.05949.x

DO - 10.1111/j.1365-2141.2005.05949.x

M3 - Article

VL - 132

SP - 774

EP - 783

JO - British Journal of Haematology

JF - British Journal of Haematology

SN - 1365-2141

IS - 6

ER -